# Methionine restriction provides sex-specific protection against high-fat diet-induced adiposity, peripheral insulin resistance, and neuroinflammation in FGF21-dependent and independent manners in mice

**Authors:** Hannah Lail, Rowan Lawrence, Filipe Pinheiro, Emily Price, Desiree Wanders

PMC · DOI: 10.1371/journal.pone.0343503 · 2026-03-10

## TL;DR

Methionine restriction helps male mice resist weight gain and insulin issues from high-fat diets, with some effects depending on a protein called FGF21.

## Contribution

The study reveals sex-specific and FGF21-dependent effects of methionine restriction on metabolic and neuroinflammatory outcomes in mice.

## Key findings

- Methionine restriction reduced body weight and adiposity in male mice regardless of diet or FGF21 status.
- FGF21 is essential for methionine restriction to improve insulin sensitivity and reduce neuroinflammation in males.
- Female mice showed limited benefits from methionine restriction, especially in adiposity and insulin signaling.

## Abstract

Excessive consumption of high-fat diets is linked to peripheral insulin resistance, neuroinflammation, and obesity. While dietary methionine restriction improves peripheral metabolic health, its effectiveness in attenuating central insulin resistance and neuroinflammation, especially in a sex-dependent manner, remains unclear. This study investigates whether methionine restriction can mitigate high-fat diet-induced alterations in insulin resistance and neuroinflammation in male and female mice and explores the role of endogenous fibroblast growth factor 21 (FGF21) in mediating these effects. We utilized wild-type and Fgf21 knockout (Fgf21-/-) mice to assess the impact of methionine restriction on body composition, insulin sensitivity, central insulin signaling, and neuroinflammation. methionine restriction reduced body weight and adiposity in males, regardless of diet or genotype. In females, methionine restriction reduced weight gain under high-fat diet conditions in both genotypes but had limited effects on female adiposity. Methionine restriction improved insulin sensitivity in WT mice, but this effect was absent in Fgf21-/- mice, highlighting the importance of FGF21. Likewise, methionine restriction enhanced hepatic insulin signaling in WT males, but not Fgf21-/- males. In contrast, methionine restriction had minimal impact on insulin signaling in the liver or brain of female mice. Methionine restriction decreased neuroinflammatory gene expression in the hippocampus of males following the high-fat diet, a process dependent on FGF21. These findings demonstrate that methionine restriction confers sex-specific protection against high-fat diet-induced metabolic disturbances, with FGF21 playing a critical role in both peripheral and central insulin sensitivity, particularly in males. Future studies should further elucidate the molecular mechanisms underlying the sex-specific effects of methionine restriction and the role of FGF21 in mediating these responses.

## Linked entities

- **Genes:** FGF21 (fibroblast growth factor 21) [NCBI Gene 26291]
- **Proteins:** FGF21 (fibroblast growth factor 21)
- **Diseases:** neuroinflammation (MONDO:0004466), obesity (MONDO:0011122)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Fgf21 (fibroblast growth factor 21) [NCBI Gene 56636] {aka Fgf8c}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il23a (interleukin 23, alpha subunit p19) [NCBI Gene 83430] {aka IL-23, p19}, Insr (insulin receptor) [NCBI Gene 16337] {aka 4932439J01Rik, CD220, D630014A15Rik, IR, IR-A, IR-B}, Synpo (synaptopodin) [NCBI Gene 104027] {aka 9030217H17Rik, 9130229N11, 9330140I15Rik}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Ppia (peptidylprolyl isomerase A) [NCBI Gene 268373] {aka Cphn, CyP-18, CypA, SP18}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 13385] {aka Dlgh4, PSD-95, PSD95, SAP90, SAP90A}, Ntrk2 (neurotrophic tyrosine kinase, receptor, type 2) [NCBI Gene 18212] {aka GP145-TrkB/GP95-TrkB, Tkrb, trk-B, trkB}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, Nrgn (neurogranin) [NCBI Gene 64011] {aka 0710001B06Rik, NG, NG/RC3, Pss1, RC3}, Irs1 (insulin receptor substrate 1) [NCBI Gene 16367] {aka G972R, IRS-1}, Cybb (cytochrome b-245, beta polypeptide) [NCBI Gene 13058] {aka CGD91-phox, Cgd, Cyd, Nox2, gp91-1, gp91phox}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Fgfr1 (fibroblast growth factor receptor 1) [NCBI Gene 14182] {aka Eask, FGFR-I, FLG, Fgfr-1, Flt-2, Fr1}, Reln (reelin) [NCBI Gene 19699] {aka reeler, rl}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}, Nr3c2 (nuclear receptor subfamily 3, group C, member 2) [NCBI Gene 110784] {aka MR, Mlr}
- **Diseases:** type 2 diabetes (MESH:D003924), adiposity (MESH:D018205), overdose (MESH:D062787), MR (MESH:D002313), liver enlargement (MESH:D006529), tauopathy (MESH:D024801), insulin resistance (MESH:D007333), hyperphagia (MESH:D006963), weight gain (MESH:D015430), obesity (MESH:D009765), FGF21 deficiency (MESH:D006130), inflammation (MESH:D007249), metabolic disturbances (MESH:D024821), neuroinflammation (MESH:D000090862)
- **Chemicals:** cysteine (MESH:D003545), lipid (MESH:D008055), carbon dioxide (MESH:D002245), glucose (MESH:D005947), polyvinylidene difluoride (MESH:C024865), 2,3-bisphosphoglyceric acid (-), fatty acid (MESH:D005227), carbohydrate (MESH:D002241), amino acid (MESH:D000596), sodium fluoride (MESH:D012969), Blood glucose (MESH:D001786), SDS (MESH:D012967), phosphate (MESH:D010710), Methionine (MESH:D008715), fat (MESH:D005223), nitrogen (MESH:D009584)
- **Species:** Homo sapiens (human, species) [taxon 9606], Adeno-associated virus (species) [taxon 272636], Mus musculus (house mouse, species) [taxon 10090]

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12974880/full.md

---
Source: https://tomesphere.com/paper/PMC12974880